A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective
Crossref DOI link: https://doi.org/10.1007/s10198-015-0679-8
Published Online: 2015-03-21
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tolley, Keith
Kemmett, Danny
Thybo, Signe
Nasr, Ruth
Smethurst, Helen
Text and Data Mining valid from 2015-03-21